Alyeska Investment Group’s GeneDx Holdings WGS Stock Holding History

Alyeska Investment Group’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-98,553	Closed	-$359K	–	669
2023 Q3	$359K	Hold	98,553	–	–	﹤0.01%	458
2023 Q2	$587K	Buy	98,553 +1	+0%	+$8	﹤0.01%	489
2023 Q1	$1.19M	Buy	98,552 +90,976	+1,201%	+$1.21M	0.01%	381
2022 Q4	$66K	Hold	7,576	–	–	﹤0.01%	402
2022 Q3	$219K	Hold	7,576	–	–	﹤0.01%	377
2022 Q2	$315K	Buy	7,576 +3,031	+67%	+$206K	﹤0.01%	540
2022 Q1	$461K	Sell	4,545 -1,516	-25%	-$169K	0.01%	552
2021 Q4	$892K	Buy	6,061 +4,546	+300%	+$1.02M	0.01%	541
2021 Q3	$380K	Buy	1,515 +757	+100%	+$260K	﹤0.01%	643
2021 Q2	$350K	Hold	758	–	–	﹤0.01%	666
2021 Q1	$372K	Buy	+758	New	+$394K	﹤0.01%	688

Other funds holding WGS

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Alyeska Investment Group's WGS Position: Q4 2023 in Review

Alyeska Investment Group sold out of GeneDx Holdings (WGS) in Q4 2023, closing a stake of 98,553 shares — an estimated $359K sold.

Alyeska Investment Group first reported a position in WGS in Q1 2021 and held it in 11 quarters. The position peaked at $1.19M in Q1 2023. 48 funds tracked by Wall St. Rank hold WGS as of Q4 2023.

Alyeska Investment Group reported no remaining GeneDx Holdings position as of Q4 2023 after selling out during the quarter.
Alyeska Investment Group sold 98,553 GeneDx Holdings shares in Q4 2023, an estimated $359K.
Alyeska Investment Group first reported a position in GeneDx Holdings in Q1 2021 and held it in 11 quarters.
Alyeska Investment Group's GeneDx Holdings position peaked at $1.19M in Q1 2023.
48 funds tracked by Wall St. Rank held GeneDx Holdings as of Q4 2023.

Based on Alyeska Investment Group's 13F filing for Q4 2023, filed 14 Feb 2024.